Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.64
- Piotroski Score 4.00
- Grade Overweight
- Symbol (TKNO)
- Company Alpha Teknova, Inc.
- Price $4.85
- Changes Percentage (2.97%)
- Change $0.14
- Day Low $4.53
- Day High $4.85
- Year High $5.46
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.05
- Trailing P/E Ratio -1.67
- Forward P/E Ratio -1.67
- P/E Growth -1.67
- Net Income $-36,780,000
Income Statement
Quarterly
Annual
Latest News of TKNO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's Why Alpha Teknova (TKNO) Underperformed in Q2
Conestoga Capital Advisors released its Q2 2024 investor letter, noting market moderation and performance. They highlighted Alpha Teknova, Inc. (NASDAQ:TKNO) as a top performer, with significant gains...
By Yahoo! Finance | 1 month ago
